Oxford COVID-19 vaccine: All you need to know about price, trial, production in India2 min read 22 Jul 2020, 04:37 PM IST
AstraZeneca has joined Serum Institute of India (SII) to produce the potential COVID-19 vaccine in India
Serum Institute will produce 3 to 4 million doses of Oxford's COVID-19 vaccine this year, Poonawalla said
Coronavirus has infected more than 1.5 crore people across the globe since outbreak. No vaccine has been developed yet, to protect against the deadly novel virus. The scientists and researchers are scrambling to develop a COVID-19 vaccine. At present, three vaccine candidates are at the final stage of their trials. Among them, Oxford's COVID-19 vaccine has shown a positive result in its initial trial. According to a report published in the British medical journal, The Lancet, the COVID-19 vaccine produced a dual immune response in people aged 18 to 55.